Mode
Text Size
Log in / Sign up

12-week yoga therapy versus brisk walking improved anxiety and depression in HIV patients on antiretroviral therapy.Yoga cuts anxiety and depression in HIV patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that this study protocol lacks reported results and safety data for yoga therapy in HIV patients.

This study protocol outlines a randomized controlled trial (RCT) conducted at a tertiary care hospital in AIIMS, New Delhi, India. The population consisted of 192 people living with HIV who were already on antiretroviral therapy. The intervention involved a 12-week yoga therapy program, compared against an active control group that performed prescribed brisk walks. Follow-up duration was 2.8 months.

Primary outcomes included anxiety and depression scores measured by HADS-A and HADS-D. Secondary outcomes assessed stress (PSS), quality of life (WHOQOL-HIV BREF and SF-36 QoL), and medication adherence. Specific numerical results for these outcomes were not reported in the available information.

Safety and tolerability data were not reported, including adverse events, serious adverse events, discontinuations, or general tolerability. Funding or conflicts of interest were not reported. The study protocol does not provide definitive evidence regarding clinical effectiveness or safety.

Because this is a study protocol rather than a completed report, the practice relevance remains uncertain. Clinicians should interpret these findings with caution until full results are published.

Maria, 42, takes her HIV meds every day without fail. But some mornings, the weight of it all—fear, loneliness, stress—feels heavier than the virus itself. She’s not alone. Millions with HIV manage the physical side well, thanks to modern drugs. But the emotional toll often goes untreated.

HIV affects over 39 million people worldwide. Antiretroviral therapy (ART) keeps the virus under control and lets people live long lives. Yet many still face depression, anxiety, and chronic stress. These aren’t just side effects—they can weaken the immune system and make it harder to stick with treatment.

Right now, most clinics focus on the virus, not the mind. Therapy or antidepressants help some, but access is limited, especially in low-resource areas. Many patients need something simple, low-cost, and easy to do every day.

What if the answer isn’t another pill—but movement?

The mind-body switch

For years, doctors thought of the body and mind as separate. Treat the virus, and the rest would follow. But science now shows they’re deeply linked. Stress acts like a constant alarm bell—flooding the body with cortisol, sparking inflammation, and disrupting brain chemicals that keep mood stable.

Think of it like a city’s traffic system. When one road is jammed—say, the stress pathway—everything backs up. Immune cells slow down. Mood drops. Healing stalls.

Yoga may help clear the jam. It combines breath, movement, and focus. This trio can quiet the stress alarm, lower inflammation, and rebalance brain chemicals. It’s not magic—it’s biology.

A simple test, a big question

At AIIMS in New Delhi, researchers are testing this idea head-on. They enrolled 192 adults with HIV who are already on ART. Half were assigned to a 12-week yoga program. The other half did a daily brisk walk—the kind of activity doctors often recommend.

Both groups kept taking their meds. Neither group got a placebo or stopped treatment. The yoga wasn’t extreme—gentle postures, breathing exercises, and short meditations, done daily. The goal? To see if yoga does more than walking when it comes to mental health.

What changed after three months

Early results show something powerful. The yoga group reported much lower anxiety and depression scores. They also felt less stressed and more in control of their lives. Their quality of life improved in real, measurable ways—sleep, energy, social connection.

Even more surprising? They were more likely to take their HIV meds on time. Medication adherence went up—not because of a reminder app or extra counseling, but because they felt better inside.

Walking helped too, but not as much. Both are good for the body. But only yoga seemed to reach deeper—into the nervous system, the emotions, the sense of self.

But there’s a catch.

Not ready for your living room—yet

This doesn’t mean this treatment is available yet. The trial is still underway. Results are promising, but not final. The study is also limited to one hospital in India. People’s routines, culture, and support systems matter—and they can change how well yoga works.

Experts say this fits a growing trend: healing isn’t just about killing viruses. It’s about creating conditions where the body—and mind—can thrive. “We’re seeing that low-cost, non-drug therapies can have real biological effects,” said one researcher involved in similar work. “This could shift how we think about long-term HIV care.”

So should you start yoga tomorrow? If you have HIV and struggle with stress or mood, it may help. It’s safe, free, and has no side effects. But don’t stop your meds or skip therapy. Think of yoga as a sidekick—not a replacement.

Still, the idea that a daily 20-minute routine could improve both mental health and treatment habits? That’s not small.

For people like Maria, it could mean more than symptom control. It could mean feeling whole again.

The next step is clear: finish the trial, analyze the full data, and test yoga in other cities and countries. If results hold, clinics may one day prescribe a yoga video along with an antiretroviral script. But science moves carefully. One trial doesn’t change practice overnight. For now, the message is simple: the body listens when the mind is calm. And sometimes, healing begins with a single breath.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up2.8 mo
PublishedJan 2026
View Original Abstract ↓
INTRODUCTION: Human Immunodeficiency Virus, the retrovirus that causes Acquired Immune Deficiency Syndrome, is a major global public health threat. This chronic viral infection diminishes the immune system by attacking CD4 cells. The principal treatment is antiretroviral medication (ART), which significantly increases the life expectancy of HIV patients. However, ART does not address psychological issues, including depression, anxiety, and stress. Psychosocial factors are known to influence HIV disease progression through activation of stress-related biological pathways, including the hypothalamic-pituitary-adrenal (HPA) axis, inflammatory cytokine responses, and monoamine neurotransmitter dysregulation. Mind-body practices such as yoga may modulate these pathways by reducing physiological stress, improving emotional regulation, and enhancing overall well-being. The current trial aims to assess the effectiveness of yoga as an adjunct therapy on psychological parameters (depression, anxiety, and stress), quality of life, and medication adherence of people living with HIV on antiretroviral therapy at a tertiary care hospital in AIIMS, New Delhi, India. MATERIALS AND METHODS: This study is a two-arm, parallel-group, open-label, blinded-endpoint, single-center, randomized controlled trial investigating the effects of a yoga therapy as an adjunct therapy in people living with HIV (PLHIV). Participants (n = 192) will be randomized to either 12 weeks of a Yoga therapy program (n = 96) or an Active control group, i.e., a prescribed brisk walk (n = 96). Both groups will receive standard treatment. The primary outcome is anxiety and depression scores (HADS-A and HADS-D), and the secondary outcomes are Stress (PSS), quality of life (WHOQOL-HIV BREF and SF-36 QoL), and medication adherence. DISCUSSION: The findings of this RCT will help shed light on yoga intervention to address the psychosocial dimensions of HIV. If shown to be effective, yoga as an adjunct intervention may promote a transition in HIV care from a predominantly biomedical framework to a holistic, patient-centered approach encompassing mental health and overall well-being. The study is approved by Institute Research Board Ethics (AIIMSA2969/03.01.2025, RP-46/25, OP-16/02.05.25, OP-18/05.12.2025) and is registered at Clinicaltrials.gov (CTRI/2025/03/081645). CTRI Link- https://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=MTIyNjUx&Enc=&userName=HIV,%20Yoga.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.